This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39:1300–6.
Whimbey E, Elting LS, Couch RB, Lo W, Williams L, Champlin RE, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 1994;13:437–40.
Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e200–12.
Dulek DE, de St Maurice A, Halasa NB. Vaccines in pediatric transplant recipients-Past, present, and future. Pediatr Transplant. 2018;22:e13282.
Ryan AL, Wadia UD, Jacoby P, Cheung LC, Kerr F, Fraser C, et al. Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant. Bone Marrow Transplant. 2019. https://doi.org/10.1038/s41409-019-0728-5. [Epub ahead of print]
Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook, 10th Ed. Canberra: Australian Government Department of Health, 2013.
WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza, 2011. Available from URL: https://www.who.int/influenza/gisrs_laboratory/manual_diagnosis_surveillance_influenza/en/. Accessed 15 Oct 2019.
Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. European Agency for the Evaluation of Medicinal Products (EMEA). March 1997.
Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI, et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant. 2001;28:775–81.
Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G, et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis. 2000;30:342–8.
Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, et al. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine. 2011;29:1777–82.
Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant. 1993;11:1–5.
Funding
RSK (NHMRC APP1142627) and CCB (NHMRC APP1111596) are supported by Fellowships from the National Health and Medical Research Council of Australia. This study was funded by a Perth Children’s Hospital Foundation Project Grant and a Pfizer Cancer Competitive Research Grant. The WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, is supported by the Australian Government Department of Health. This study was approved by the Child and Adolescent Health Service Ethics Committee (Ethics Approval Number 1988/EP), with ethical approval granted at all sites under the National Mutual Acceptance agreement. The study was registered on the Australian New Zealand Clinical Trials Registry (ACTRN12614000240640).
Author information
Authors and Affiliations
Contributions
UDW, PCR and RSK conceived and designed the study. ALR, FK, CF, HT and RSK recruited patients onto the study. LAC, KLL and IGB performed serological analysis. PJ performed statistical analysis. ALR, PJ and RSK analysed and interpreted the results. ALR and RSK wrote the paper. All authors edited and approved the final version of the paper for submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ryan, A.L., Wadia, U.D., Jacoby, P. et al. Immunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplant. Bone Marrow Transplant 55, 1829–1831 (2020). https://doi.org/10.1038/s41409-019-0770-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-019-0770-3